The summaries are free for public use. ARTHROS will continue to add and archive summaries of articles deemed relevant to ARTHROS by our Faculty.
| 1 | |
Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients |
Curr Opin Pharmacol. 2022 Dec 27;68:102320. doi: 10.1016/j.coph.2022.102320.Online ahead of print.
|
| 2 | |
Olokizumab, a monoclonal antibody against interleukin-6, in combination with methotrexate in patients with rheumatoid arthritis inadequately controlled by tumour necrosis factor inhibitor therapy: efficacy and safety results of a randomised controlled phase III study |
Ann Rheum Dis. 2022 Dec;81(12):1661-1668. doi: 10.1136/ard-2022-222630.Epub 2022 Sep 15.
Eugen Feist 1, Saeed Fatenejad 2, Sergey Grishin 3, Elena Korneva 4, Michael E Luggen 5, Evgeniy Nasonov 6, Mikhail Samsonov 7, Josef S Smolen 8, Roy M Fleischmann 9 10 |
| 3 | |
Oral Microbiome in Pre-Rheumatoid Arthritis: The Role of Aggregatibacter Actinomycetemcomitans in Bacterial Composition |
Cureus. 2022 Dec 5;14(12):e32201. doi: 10.7759/cureus.32201.eCollection 2022 Dec.
Arathi Kulkarni 1, Michelle D Beckler 2, Sahar S Amini 3, Marc M Kesselman 4 |
| 4 | |
Lifestyle Factors and Their Influence on Rheumatoid Arthritis: A Narrative Review |
J Clin Med. 2022 Dec 2;11(23):7179. doi: 10.3390/jcm11237179.
|
| 5 | |
Increased Risk of Cardiovascular Diseases in Rheumatoid Arthritis: A Systematic Review |
Cureus. 2022 Dec 8;14(12):e32308. doi: 10.7759/cureus.32308.eCollection 2022 Dec.
Hadi Farhat 1 2, Huma Irfan 3 2, Kanmani Muthiah 4, Namratha Pallipamu 5 6, Sogand Taheri 7, Suvedha S Thiagaraj 6, Twisha S Shukla 8, Sai Dheeraj Gutlapalli 6, Sheiniz Giva 9 2, Sai Sri Penumetcha 10 11 |
| 6 | |
The pathogenesis of rheumatoid arthritis |
Immunity. 2022 Dec 13;55(12):2255-2270. doi: 10.1016/j.immuni.2022.11.009.
|
| 7 | |
JAK inhibitors, cardiovascular and thromboembolic events: what we know and what we would like to know |
Clin Rheumatol. 2022 Dec 13. doi: 10.1007/s10067-022-06471-x.Online ahead of print.
|
| 8 | |
Targeting fibroblast-like synoviocytes in rheumatoid arthritis |
Curr Opin Pharmacol. 2022 Dec;67:102304. doi: 10.1016/j.coph.2022.102304.Epub 2022 Oct 10.
|
| 9 | |
Injectable Drug Delivery Systems for Osteoarthritis and Rheumatoid Arthritis |
ACS Nano. 2022 Dec 27;16(12):19665-19690. doi: 10.1021/acsnano.2c06393.Epub 2022 Dec 13.
Maria Chiara Bruno 1, Maria Chiara Cristiano 2, Christian Celia 3 4, Nicola d'Avanzo 1 3, Antonia Mancuso 2, Donatella Paolino 2, Joy Wolfram 5 6, Massimo Fresta 1 |
| 10 | |
Artificial intelligence and the future of radiographic scoring in rheumatoid arthritis: a viewpoint |
Arthritis Res Ther. 2022 Dec 12;24(1):268. doi: 10.1186/s13075-022-02972-x.
Alix Bird 1 2, Lauren Oakden-Rayner 3 4, Christopher McMaster 5, Luke A Smith 3 4, Minyan Zeng 3 4, Mihir D Wechalekar 6, Shonket Ray 7, Susanna Proudman 8, Lyle J Palmer 3 4 |
| 11 | |
Management of patients with rheumatoid arthritis by telemedicine: connected monitoring. A randomized controlled trial |
Joint Bone Spine. 2022 Oct;89(5):105368.doi: 10.1016/j.jbspin.2022.105368. Epub 2022 Mar 4.
Laurene Bernard 1, Verushka Valsecchi 1, Thibault Mura 2, Safa Aouinti 2, Guillaume Padern 1, Rosanna Ferreira 1, Jenica Pastor 3, Christian Jorgensen 1, Grégoire Mercier 3, Yves-Marie Pers 4 |
| 12 | |
Tapering biologic DMARDs in rheumatoid arthritis |
Curr Opin Pharmacol. 2022 Oct 20;67:102308. doi: 10.1016/j.coph.2022.102308.Online ahead of print.
|
| 13 | |
Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial |
Semin Arthritis Rheum. 2022 Dec;57:152109.doi: 10.1016/j.semarthrit.2022.152109. Epub 2022 Oct 21.
L Hartman 1, M El Alili 2, M Cutolo 3, D Opris 4, Jap Da Silva 5, Z Szekanecz 6, F Buttgereit 7, P Masaryk 8, R Bos 9, M R Kok 10, S Paolino 3, Vmh Coupé 11, W F Lems 12, M Boers 11, GLORIA consortium |
| 14 | |
Ocular manifestations of rheumatoid arthritis |
Curr Opin Ophthalmol. 2022 Nov 1;33(6):551-556.doi: 10.1097/ICU.0000000000000890. Epub 2022 Sep 16.
|
| 15 | |
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis |
Rheum Dis Clin North Am. 2022 Nov;48(4):799-811. doi: 10.1016/j.rdc.2022.06.003.
|
| 16 | |
When and how should we use imaging in individuals at risk of rheumatoid arthritis? |
Front Med (Lausanne). 2022 Nov 23;9:1058510. doi: 10.3389/fmed.2022.1058510.eCollection 2022.
|
| 17 | |
Combined Conventional Synthetic Disease Modifying Therapy vs. Infliximab for Rheumatoid Arthritis: Emulating a Randomized Trial in Observational Data |
Clin Pharmacol Ther. 2022 Oct;112(4):836-845.doi: 10.1002/cpt.2673. Epub 2022 Jun 23.
Andrei Barbulescu 1, Johan Askling 1 2, Saedis Saevarsdottir 1 3, Seoyoung C Kim 4 5, Thomas Frisell 1 |
| 18 | |
The exposome in rheumatoid arthritis |
Joint Bone Spine. 2022 Nov;89(6):105455. doi: 10.1016/j.jbspin.2022.105455.Epub 2022 Aug 12.
Jerome Biton 1, Nathalie Saidenberg-Kermanac'h 2, Patrice Decker 1, Marie-Christophe Boissier 3, Luca Semerano 3, Johanna Sigaux 4 |
| 20 | |
Artificial Intelligence and Deep Learning for Rheumatologists |
Arthritis Rheumatol. 2022 Dec;74(12):1893-1905. doi: 10.1002/art.42296.Epub 2022 Oct 26.
Christopher McMaster 1, Alix Bird 2, David F L Liew 3, Russell R Buchanan 4, Claire E Owen 4, Wendy W Chapman 5, Douglas E V Pires 6 |
| 21 | |
Outcomes of the First Episode of STEMI in Rheumatoid Arthritis Patients from the National Inpatient Sample Database, 2016-2019 |
Curr Probl Cardiol. 2022 Oct;47(10):101310. doi: 10.1016/j.cpcardiol.2022.101310.Epub 2022 Jul 8.
Amar Suwal 1, Biraj Shrestha 2, Devy Setyono 3, Bidhya Poudel 4, Anthony Donato 2 |
| 22 | |
Opportunistic infections associated with Janus kinase inhibitor treatment for rheumatoid arthritis: A structured literature review |
Semin Arthritis Rheum. 2022 Oct 29;58:152120.doi: 10.1016/j.semarthrit.2022.152120. Online ahead of print.
Kevin Winthrop 1, John Isaacs 2, Leonard Calabrese 3, Deepali Mittal 4, Supriya Desai 4, Jane Barry 5, Sander Strengholt 5, James Galloway 6 |
| 23 | |
Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis |
Cardiovasc Drugs Ther. 2022 Oct 5;1-8. doi: 10.1007/s10557-022-07387-z.Online ahead of print.
Andres Cordova Sanchez 1, Farzam Khokhar 2, Danielle A Olonoff 2, Robert L Carhart 3 |
| 24 | |
Diet and the risk of rheumatoid arthritis - A systematic literature review |
Semin Arthritis Rheum. 2022 Oct 28;58:152118.doi: 10.1016/j.semarthrit.2022.152118. Online ahead of print.
Rebecka Bäcklund 1, Isabel Drake 2, Ulf Bergström 3, Michele Compagno 3, Emily Sonestedt 4, Carl Turesson 3 |
| 25 | |
Genetic Liability to Rheumatoid Arthritis in Relation to Coronary Artery Disease and Stroke Risk |
Arthritis Rheumatol. 2022 Oct;74(10):1638-1647. doi: 10.1002/art.42239.Epub 2022 Aug 17.
Shuai Yuan 1, Paul Carter 2, Amy M Mason 2, Fangkun Yang 3, Stephen Burgess 2, Susanna C Larsson 4 |
| 26 | |
Plain language summary of the VOLTAIRE-RA in patients with moderate-to-severe rheumatoid arthritis |
Immunotherapy. 2022 Oct;14(15):1183-1190. doi: 10.2217/imt-2022-0106.Epub 2022 Sep 6.
|
| 27 | |
Prevention of rheumatoid arthritis: A systematic literature review of preventive strategies in at-risk individuals |
Autoimmun Rev. 2022 Oct 21;103217. doi: 10.1016/j.autrev.2022.103217.Online ahead of print.
Giulia Frazzei 1, Anne Musters 1, Niek de Vries 1, Sander W Tas 2, Ronald F van Vollenhoven 1 |
| 28 | |
Risk factors for osteoporosis and fractures in rheumatoid arthritis |
Best Pract Res Clin Rheumatol. 2022 Oct 5;101773. doi: 10.1016/j.berh.2022.101773.Online ahead of print.
Rahaf Baker 1, Radhika Narla 2, Joshua F Baker 3, Katherine D Wysham 4 |
| 29 | |
Rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis epidemiology in England from 2004 to 2020: An observational study using primary care electronic health record data |
Lancet Reg Health Eur. 2022 Oct 10;23:100519. doi: 10.1016/j.lanepe.2022.100519.eCollection 2022 Dec.
Ian C Scott 1 2, Rebecca Whittle 1, James Bailey 1, Helen Twohig 1, Samantha L Hider 1 2, Christian D Mallen 1 2, Sara Muller 1, Kelvin P Jordan 1 |
| 30 | |
Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature |
Intern Med J. 2022 Oct;52(10):1717-1723. doi: 10.1111/imj.15390. Epub 2022 May 23.
Jianna He 1, Luke Williamson 1, Ken Cai 1, Peter Wong 1 2, Allan Sturgess 3, John Taper 4, Nicholas Manolios 1 5 |
| 31 | |
Rheumatoid Arthritis in Spine Surgery: A Systematic Review and Meta-Analysis |
Global Spine J. 2022 Sep;12(7):1583-1595. doi: 10.1177/21925682211057543.Epub 2022 Mar 18.
Benjamin D Streufert 1, Chiduziem Onyedimma 2, Yagiz U Yolcu 2, Abdul Karim Ghaith 2, Benjamin D Elder 2, Ahmad Nassr 1, Bradford Currier 1, Arjun S Sebastian 1, Mohamad Bydon 2 |
| 32 | |
Correlates of physical activity in adults with spondyloarthritis and rheumatoid arthritis: a systematic review |
Rheumatol Int. 2022 Oct;42(10):1693-1713. doi: 10.1007/s00296-022-05142-z.Epub 2022 Jun 8.
Thomas Ingram 1 2, Raj Sengupta 3 4, Martyn Standage 5, Rosie Barnett 5 3, Peter Rouse 6 |
| 33 | |
Systematic Review of Outcomes and Patient Experience With Virtual Care in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1484-1492. doi: 10.1002/acr.24586.Epub 2022 May 24.
Lily Han 1, Glen S Hazlewood 2, Cheryl Barnabe 2, Claire E H Barber 2 |
| 34 | |
Representation of adults with rheumatoid arthritis in US-based randomized controlled exercise trials: a systematic review with meta-analysis |
Clin Rheumatol. 2022 Sep 24. doi: 10.1007/s10067-022-06360-3.Online ahead of print.
|
| 35 | |
2022 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty |
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1399-1408. doi: 10.1002/acr.24893.Epub 2022 Jun 19.
Susan M Goodman 1, Bryan D Springer 2, Antonia F Chen 3, Marshall Davis 4, David R Fernandez 1, Mark Figgie 1, Heather Finlayson 5, Michael D George 6, Jon T Giles 7, Jeremy Gilliland 8, Brian Klatt 9, Ronald MacKenzie 1, Kaleb Michaud 10, Andy Miller 1, Linda Russell 1, Alexander Sah 11, Matthew P Abdel 12, Beverly Johnson 13, Lisa A Mandl 1, Peter Sculco 1, Marat Turgunbaev 14, Amy S Turner 14, Adolph Yates Jr 9, Jasvinder A Singh 15 |
| 36 | |
Effectiveness of ergonomic interventions on work activity limitations in adults with rheumatoid arthritis: A systematic review |
Work. 2022 Jul 23. doi: 10.3233/WOR-210016. Online ahead of print.
Heather Jones 1, Megan Young 1, Kyndel Guyton 1, Emily Idemoto 1, Alicia Ferraro 1, Rawan AlHeresh 1 |
| 37 | |
Examining the Relationship Between Rheumatoid Arthritis, Multimorbidity, and Adverse Health-Related Outcomes: A Systematic Review |
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1500-1512. doi: 10.1002/acr.24587.Epub 2022 May 27.
Jordan Canning 1, Stefan Siebert 1, Bhautesh D Jani 1, Louisa Harding-Edgar 1, Isla Kempe 1, Frances S Mair 1, Barbara I Nicholl 1 |
| 38 | |
Clinical prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: A systematic review and meta-analysis |
Semin Arthritis Rheum. 2022 Oct;56:152076. doi: 10.1016/j.semarthrit.2022.152076.Epub 2022 Jul 27.
Celina K Gehringer 1, Glen P Martin 2, Kimme L Hyrich 3, Suzanne M M Verstappen 3, Jamie C Sergeant 4 |
| 39 | |
Acute effects of exercise on pain symptoms, clinical inflammatory markers and inflammatory cytokines in people with rheumatoid arthritis: a systematic literature review |
Ther Adv Musculoskelet Dis. 2022 Aug 16;14:1759720X221114104.doi: 10.1177/1759720X221114104. eCollection 2022.
Christopher Balchin 1, Ai Lyn Tan 2, Joshua Golding 1, Lesley-Anne Bissell 2, Oliver J Wilson 1, Jim McKenna 1, Antonios Stavropoulos-Kalinoglou 3 |
| 40 | |
Inhibition of structural joint damage progression with upadacitinib in rheumatoid arthritis: 1-year outcomes from the SELECT phase 3 program |
Rheumatology (Oxford). 2022 Aug 3;61(8):3246-3256.doi: 10.1093/rheumatology/keab861.
Charles G Peterfy 1, Vibeke Strand 2, Alan Friedman 3, Stephen Hall 4, Eduardo Mysler 5, Patrick Durez 6, Xenofon Baraliakos 7, Jeffrey V Enejosa 3, Tim Shaw 3, Yihan Li 3, Su Chen 3, In-Ho Song 3 |
| 41 | |
A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis |
Semin Arthritis Rheum. 2022 Oct;56:152072.doi: 10.1016/j.semarthrit.2022.152072. Epub 2022 Jul 16.
Maria A Lopez-Olivo 1, Jessica T Foreman 2, Cheuk Leung 3, Heather Y Lin 3, Tiffany Westrich-Robertson 4, Catherine Hofstetter 5, Jude K A des Bordes 6, Anne Lyddiatt 7, Amye Leong 8, Irmgard U Willcockson 9, Susan K Peterson 10, Maria E Suarez-Almazor 11 |
| 43 | |
Risk factors for anti-drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial |
J Intern Med. 2022 Sep;292(3):477-491.doi: 10.1111/joim.13495. Epub 2022 Apr 26.
Marthe Kirkesaether Brun 1 2, Guro Løvik Goll 1, Kristin Kaasen Jørgensen 3, Joseph Sexton 1, Johanna Elin Gehin 2 4, Øystein Sandanger 5, Inge Christoffer Olsen 6, Rolf Anton Klaasen 4, David John Warren 4, Cato Mørk 7, Tore K Kvien 1 2, Jørgen Jahnsen 2 3, Nils Bolstad 4, Espen A Haavardsholm 1 2, Silje Watterdal Syversen 1 |
| 44 | |
Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Sep;74(9):1477-1483.doi: 10.1002/acr.24583. Epub 2022 May 24.
Roy Fleischmann 1, Jingyu Liu 2, Julie Zhu 2, Oscar G Segurado 3, Daniel E Furst 4 |
| 45 | |
Treatment Guidelines in Rheumatoid Arthritis |
Rheum Dis Clin North Am. 2022 Aug;48(3):679-689. doi: 10.1016/j.rdc.2022.03.005.Epub 2022 Jul 5.
|
| 46 | |
'Difficult to treat' rheumatoid arthritis: current position and considerations for next steps |
RMD Open. 2022 Jul;8(2):e002387. doi: 10.1136/rmdopen-2022-002387.
|
| 47 | |
What is the impact of sex hormones on the pathogenesis of rheumatoid arthritis? |
Front Med (Lausanne). 2022 Jul 22;9:909879. doi: 10.3389/fmed.2022.909879.eCollection 2022.
|
| 48 | |
Cost-effectiveness of motivational counselling and text reminders in patients with rheumatoid arthritis: results based on a randomised clinical trial |
RMD Open. 2022 Jul;8(2):e002304.doi: 10.1136/rmdopen-2022-002304.
Jan Sørensen 1 2, Bente Appel Esbensen 3 4, Mette Aadahl 4 5, Merete Lund Hetland 6 7, Tanja Thomsen 5 8 |
| 49 | |
Appraising the causal role of smoking in multiple diseases: A systematic review and meta-analysis of Mendelian randomization studies |
EBioMedicine. 2022 Jul 8;82:104154. doi: 10.1016/j.ebiom.2022.104154. Online ahead of print.
|
| 50 | |
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases |
Am J Clin Dermatol. 2022 Jul;23(4):449-457. doi: 10.1007/s40257-022-00692-1.Epub 2022 Apr 29.
Ronald Berna 1, Misha Rosenbach 1, David J Margolis 1 2, Nandita Mitra 1 2, Emily Baumrin 3 |
| 51 | |
Systematic Review of Safety and Efficacy of IL-1-Targeted Biologics in Treating Immune-Mediated Disorders |
Front Immunol. 2022 Jul 6;13:888392. doi: 10.3389/fimmu.2022.888392. eCollection 2022.
|
| 52 | |
Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis |
Ann Rheum Dis. 2022 Jul;81(7):937-943. doi: 10.1136/annrheumdis-2022-222338.Epub 2022 Apr 25.
Lotte van Ouwerkerk 1, Andriko Palmowski 2, Isabell S Nevins 3, Frank Buttgereit 2, Patrick Verschueren 4, Josef S Smolen 5, Robert Bm Landewé 6 7, Johannes Jw Bijlsma 8, Andreas Kerschbaumer 5, René Westhovens 4, Tom Wj Huizinga 3, Cornelia F Allaart 3, Sytske Anne Bergstra 3 |
| 53 | |
Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis |
Rheumatology (Oxford). 2022 Jul 6;61(7):2815-2825.doi: 10.1093/rheumatology/keab839.
Paul Studenic 1 2, Gregor Bond 3, Andreas Kerschbaumer 1, Manuel Bécède 1, Karel Pavelka 4 5, Dmitry Karateev 6, Jutta Stieger 7, Rudolf Puchner 8, Ruediger B Mueller 9, Elisabeth Puchhammer-Stöckl 10, Martina Durechova 1, Michaela Loiskandl 1, Thomas Perkmann 11, Martina Olejarova 4 5, Elena Luchikhina 6, Carl-Walter Steiner 1, Michael Bonelli 1, Josef S Smolen 1, Daniel Aletaha 1 |
| 54 | |
Clinical predictors of response to methotrexate in patients with rheumatoid arthritis: a machine learning approach using clinical trial data |
Arthritis Res Ther. 2022 Jul 1;24(1):162.doi: 10.1186/s13075-022-02851-5.
Stephanie Q Duong 1, Cynthia S Crowson 1 2, Arjun Athreya 3, Elizabeth J Atkinson 1, John M Davis 3rd 2, Kenneth J Warrington 2, Eric L Matteson 2, Richard Weinshilboum 3, Liewei Wang 3, Elena Myasoedova 4 5 |
| 55 | |
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial |
Ann Rheum Dis. 2022 Jul;81(7):925-936.doi: 10.1136/annrheumdis-2021-221957. Epub 2022 May 31.
Maarten Boers 1 2, Linda Hartman 3 2, Daniela Opris-Belinski 4, Reinhard Bos 5, Marc R Kok 6, Jose Ap Da Silva 7, Eduard N Griep 8, Ruth Klaasen 9, Cornelia F Allaart 10, Paul Baudoin 11, Hennie G Raterman 12, Zoltan Szekanecz 13, Frank Buttgereit 14, Pavol Masaryk 15, L Thomas Klausch 3, Sabrina Paolino 16, Annemarie M Schilder 5, Willem F Lems 2, Maurizio Cutolo 16, GLORIA Trial consortium |
| 56 | |
Impact of age on the efficacy and safety of peficitinib (ASP015K) for the treatment of rheumatoid arthritis |
Mod Rheumatol. 2022 Jul 1;32(4):696-707. doi: 10.1093/mr/roab058.
Yoshiya Tanaka 1, Tsutomu Takeuchi 2, Daisuke Kato 3, Yuichiro Kaneko 3, Musashi Fukuda 3, Daisuke Miyatake 3 |
| 58 | |
Tofacitinib and risk of cardiovascular outcomes: results from the Safety of TofAcitinib in Routine care patients with Rheumatoid Arthritis (STAR-RA) study |
Ann Rheum Dis. 2022 Jun;81(6):798-804.doi: 10.1136/annrheumdis-2021-221915. Epub 2022 Jan 13.
Farzin Khosrow-Khavar 1, Seoyoung C Kim 1 2, Hemin Lee 1, Su Been Lee 1, Rishi J Desai 3 |
| 59 | |
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial |
Nat Med. 2022 Jun;28(6):1256-1268. doi: 10.1038/s41591-022-01789-0.Epub 2022 May 19.
Felice Rivellese # 1 2, Anna E A Surace # 1 2, Katriona Goldmann 1 2, Elisabetta Sciacca 1 2, Cankut Çubuk 1 2, Giovanni Giorli 1 2, Christopher R John 1 2, Alessandra Nerviani 1, Liliane Fossati-Jimack 1, Georgina Thorborn 1, Manzoor Ahmed 1, Edoardo Prediletto 1, Sarah E Church 3, Briana M Hudson 3, Sarah E Warren 3, Paul M McKeigue 4, Frances Humby 1, Michele Bombardieri 1, Michael R Barnes 2, Myles J Lewis 5 6, Costantino Pitzalis 7, R4RA collaborative group |
| 60 | |
Patient involvement in rheumatoid arthritis care to improve disease activity-based management in daily practice: A randomized controlled trial |
Patient Educ Couns. 2022 May;105(5):1244-1253.doi: 10.1016/j.pec.2021.08.013. Epub 2021 Aug 14.
Marieke J Spijk-de Jonge 1, Julia M Weijers 2, Steven Teerenstra 3, Glyn Elwyn 4, Mart Afj van de Laar 5, Piet Lcm van Riel 6, Anita Mp Huis 2, Marlies Ejl Hulscher 2 |
| 61 | |
Different types of foot orthoses effect on gait mechanics in patients with rheumatoid arthritis |
J Biomech. 2022 Jun;139:110496.doi: 10.1016/j.jbiomech.2021.110496. Epub 2021 Apr 30.
Morten Bilde Simonsen 1, Rogerio Pessoto Hirata 2, Ketill Næsborg-Andersen 3, Peter Derek Christian Leutscher 4, Kim Hørslev-Petersen 5, James Woodburn 6, Michael Skipper Andersen 7 |
| 62 | |
Accuracy and tolerability of self-sampling of capillary blood for analysis of inflammation and autoantibodies in rheumatoid arthritis patients-results from a randomized controlled trial |
Arthritis Res Ther. 2022 May 25;24(1):125.doi: 10.1186/s13075-022-02809-7.
Johannes Knitza 1 2 3, Koray Tascilar 4 5, Nicolas Vuillerme 6 7 8, Ekaterina Eimer 9, Paul Matusewicz 9, Giulia Corte 4 5, Louis Schuster 4 5, Timothée Aubourg 6 8, Gerlinde Bendzuck 10, Marianne Korinth 10, Corinna Elling-Audersch 10, Arnd Kleyer 4 5, Sebastian Boeltz 4 5, Axel J Hueber 4 11, Gerhard Krönke 4 5, Georg Schett 4 5, David Simon 4 5 |
| 63 | |
Association between social deprivation and disease activity in rheumatoid arthritis: a systematic literature review |
RMD Open. 2022 Apr;8(1):e002058. doi: 10.1136/rmdopen-2021-002058.
Mrinalini Dey 1 2, Amanda Busby 3, Helen Elwell 4, Heidi Lempp 5, Arthur Pratt 6 7, Adam Young 3, John Isaacs 6 7, Elena Nikiphorou 5 8 |
| 64 | |
Psychological stress in rheumatoid arthritis: a systematic scoping review |
Semin Arthritis Rheum. 2022 Apr 21;55:152014.doi: 10.1016/j.semarthrit.2022.152014. Online ahead of print.
Diederik De Cock 1, Michaël Doumen 2, Charlotte Vervloesem 3, Annelies Van Breda 3, Delphine Bertrand 3, Sofia Pazmino 3, René Westhovens 4, Patrick Verschueren 4 |
| 65 | |
Rheumatoid arthritis and myasthenia gravis: a case-based review of the therapeutic options |
Clin Rheumatol. 2022 Apr;41(4):1247-1254. doi: 10.1007/s10067-022-06062-w.Epub 2022 Jan 14.
Riccardo Bixio 1, Davide Bertelle 2, Francesca Pistillo 2, Elisa Pedrollo 2, Antonio Carletto 2, Maurizio Rossini 2, Ombretta Viapiana 2 |
| 66 | |
The Risk of Infections Associated With JAK Inhibitors in Rheumatoid Arthritis: A Systematic Review and Network Meta-analysis |
J Clin Rheumatol. 2022 Mar 1;28(2):e407-e414.doi: 10.1097/RHU.0000000000001749.
Carlos Alves 1, Ana Penedones 2, Diogo Mendes 2, Francisco Batel Marques 1 |
| 67 | |
Efficacy of tofacitinib in patients with rheumatoid arthritis stratified by baseline body mass index: an analysis of pooled data from phase 3 studies |
RMD Open. 2022 May;8(1):e002103. doi: 10.1136/rmdopen-2021-002103.
Ara H Dikranian 1, Miguel A Gonzalez-Gay 2, Frank Wellborne 3, José María Álvaro-Gracia 4, Liza Takiya 5, Lori Stockert 5, Jerome Paulissen 6, Harry Shi 6, Svitlana Tatulych 7, Jeffrey R Curtis 8 |
| 68 | |
Blood PD-1+TFh and CTLA-4+CD4+ T cells predict remission after CTLA-4Ig treatment in early rheumatoid arthritis |
Rheumatology (Oxford). 2022 Mar 2;61(3):1233-1242.doi: 10.1093/rheumatology/keab454.
Jonathan Aldridge 1, Kerstin Andersson 1, Inger Gjertsson 1, Anna-Karin Hultgård Ekwall 1, Magnus Hallström 1, Ronald van Vollenhoven 2, Anna-Carin Lundell 1, Anna Rudin 1 |
| 69 | |
An Exercise and Educational and Self-management Program Delivered With a Smartphone App (CareHand) in Adults With Rheumatoid Arthritis of the Hands: Randomized Controlled Trial |
JMIR Mhealth Uhealth. 2022 Apr 7;10(4):e35462.doi: 10.2196/35462.
Pablo Rodríguez Sánchez-Laulhé 1 2, Luis Gabriel Luque-Romero 3 4, Francisco José Barrero-García 3, Ángela Biscarri-Carbonero 3, Jesús Blanquero 1, Alejandro Suero-Pineda 1, Alberto Marcos Heredia-Rizo 1 2 |
| 70 | |
The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids |
Arthritis Rheumatol. 2022 Apr;74(4):604-611. doi: 10.1002/art.41981.Epub 2022 Feb 13.
Kenneth G Saag 1, Michele T McDermott 2, Jonathan Adachi 3, Willem Lems 4, Nancy E Lane 5, Piet Geusens 6, Robert Kees Stad 2, Li Chen 2, Shuang Huang 2, Robin Dore 7, Stanley Cohen 8 |
| 71 | |
Pharmacokinetics and pharmacodynamics of a proposed tocilizumab biosimilar MSB11456 versus both the US-licensed and EU-approved products: a randomized, double-blind trial |
Expert Rev Clin Immunol. 2022 May;18(5):533-543.doi:10.1080/1744666X.2022.2060204. Epub 2022 Apr 10.
Christian Schwabe 1, Andras Illes 2, Martin Ullmann 2, Vishal Ghori 2, Emmanuelle Vincent 2, Corinne Petit-Frere 2, Joelle Monnet 2, Anne Sophie Racault 2, Chris Wynne 3 |
| 72 | |
Effectiveness and cost-effectiveness of longstanding exercise therapy versus usual care in patients with axial spondyloarthritis or rheumatoid arthritis and severe limitations: The protocols of two parallel randomized controlled trials |
Physiother Res Int. 2022 Jan;27(1):e1933.doi: 10.1002/pri.1933. Epub 2021 Nov 15.
Maria A T van Wissen 1, Max M H Teuwen 1, Cornelia H M van den Ende 2 3, Thea P M Vliet Vlieland 1, Alfons A den Broeder 2 3, Wilbert B van den Hout 4, Wilfred F Peter 1, Dirkjan van Schaardenburg 5, Astrid M van Tubergen 6 7, Maaike G J Gademan 1 8, Salima F E van Weely 1 |
| 74 | |
Inflammation and biologic therapy in patients with rheumatoid arthritis achieving versus not achieving ACR/EULAR Boolean remission in a treat-to-target study |
RMD Open. 2022 Jan;8(1):e002013.doi: 10.1136/rmdopen-2021-002013.
Nina Paulshus Sundlisæter 1, Ulf Sundin 2, Anna-Birgitte Aga 2, Joseph Sexton 2, Hilde Berner Hammer 2 3, Till Uhlig 2 3, Tore K Kvien 2 3, Espen A Haavardsholm 2 3, Siri Lillegraven 2 |
| 75 | |
Activated Peripheral Blood B Cells in Rheumatoid Arthritis and Their Relationship to Anti-Tumor Necrosis Factor Treatment and Response: A Randomized Clinical Trial of the Effects of Anti-Tumor Necrosis Factor on B Cells |
Arthritis Rheumatol. 2022 Feb;74(2):200-211. doi: 10.1002/art.41941.Epub 2021 Dec 27.
Nida Meednu 1, Jennifer Barnard 1, Kelly Callahan 1, Andreea Coca 1, Bethany Marston 1, Ralf Thiele 1, Darren Tabechian 1, Marcy Bolster 2, Jeffrey Curtis 3, Meggan Mackay 4, Jonathan Graf 5, Richard Keating 6, Edwin Smith 2, Karen Boyle 7, Lynette Keyes-Elstein 7, Beverly Welch 8, Ellen Goldmuntz 8, Jennifer H Anolik 1 |
| 76 | |
Radiographic Progression of Structural Joint Damage Over 5 Years of Baricitinib Treatment in Patients With Rheumatoid Arthritis: Results From RA-BEYOND |
J Rheumatol. 2022 Feb;49(2):133-141. doi: 10.3899/jrheum.210346.Epub 2021 Sep 15.
Désirée van der Heijde 1, Cynthia E Kartman 2, Li Xie 3, Scott Beattie 4, Douglas Schlichting 5, Daojun Mo 4, Patrick Durez 6, Yoshiya Tanaka 7, Roy Fleischmann 8 |
| 77 | |
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE |
Rheumatology (Oxford). 2021 Dec 1;60(12):5583-5594.doi: 10.1093/rheumatology/keab158.
Vibeke Strand 1, Namita Tundia 2, Martin Bergman 3, Andrew Ostor 4, Patrick Durez 5, In-Ho Song 2, Jeffrey Enejosa 2, Casey Schlacher 2, Yan Song 6, Roy Fleischmann 7 |
| 78 | |
Cardiovascular and Cancer Risk with Tofacitinib in Rheumatoid Arthritis |
N Engl J Med. 2022 Jan 27;386(4):316-326.doi: 10.1056/NEJMoa2109927.
Steven R Ytterberg 1, Deepak L Bhatt 1, Ted R Mikuls 1, Gary G Koch 1, Roy Fleischmann 1, Jose L Rivas 1, Rebecca Germino 1, Sujatha Menon 1, Yanhui Sun 1, Cunshan Wang 1, Andrea B Shapiro 1, Keith S Kanik 1, Carol A Connell 1, ORAL Surveillance Investigators Collaborators ORAL Surveillance Investigators: Steven R Ytterberg, Deepak L Bhatt, Ted R Mikuls, Gary G Koch, Alejandro Alvarellos, Analia Alvarez, Alberto Berman, Maria Correa, Rodolfo Pardo Hidalgo, Maria Lazaro, Pablo Maid, Leonardo Naftal, Bernardo Pons-Estel, Guillermo Tate, Russell Buchanan, Maureen Rischmueller, Evangelos Romas, Robert Will, Ana Paula Assad, Valderilio Feijo Azevedo, Rubens Bonfiglioli, William Chahade, Celso Ricardo de Abreu, Ricardo de Toledo, Ari Halpern, Adriana Maria Kakehasi, Flora Marcolino, Ana Claudia Melazzi, Tatiana Muller, Mittermayer Santiago, Morton Scheinberg, Antonio Scotton, Ricardo Xavier, Cristiano Zerbini, Vladimir Kadinov, Nikolay Nikolov, Yuliy Spasov, Rumen Stoilov, Nadezhda Yordanova, Milton Baker, Isabelle Fortin, Algis Jovaisas, Clode Lessard, Jude Rodrigues, Alexander Yan, Irmgadt Goecke Sariego, Mirentxu Ines Iruretagoyena Bruce, Maria Martinez Ruiz-Esquide, Lucia Ponce Lerou, Xiao Zhang, Carlos Arteaga Unigarro, John Londono Patino, Jose Molina Restrepo, William Otero Escalante, Federico Rondon Herrera, Patricia Velez-Sanchez, Ladislav Bortlik, Šárka Forejtová, Zdenka Mosterova, Petr Nemec, Libor Novosad, Vlastimil Racek, Jan Rosa, Zuzana Stejfova, Petr Vitek, Pentti Jarvinen, Heikki Valleala, Tsang Tommy Cheung, Chak Sing Lau, Ka Lai Lee, Chi-Chiu Mok, Lai Shan Tam, Howard Amital, Alexandra Balbir-Gurman, Ori Elkayam, Yair Levy, Merav Lidar, Andrey Markov, Dror Mevorach, Yair Molad, Tatiana Reitblat, Itzhak Rosner, Moshe Tishler, Devy Zisman, Khaldoon Alawneh, Jeries Daoud, Nadeen Hilal, Jeanine Menassa, Nelly Ziade, Ping Seung Ong, Azmillah Rosman, Wahinuddin Sulaiman, Cheng Lay The, Carlos Abud-Mendoza, Hilario Avila Armengol, Mario Cardiel Rios, Sandra Carillo Vazquez, Rafael Cornejo-Ballesteros, Jose Covarrubias Cobos, Sergio Gutierrez-Urena, Fedra Irazoque-Palazuelos, Marco Maradiaga Cecena, Cesar Pacheco-Tena, Virginia Pascual-Ramos, Juan Rizo Rodriguez, Isaura Rodriguez Torres, Reinhard Bos, Jacob Van Laar, Daniel Ching, Alan Doube, Sunil Kumar, Ketna Parekh, Ana Marisela Asmat Anhuaman, Alfredo Berrocal Kasay, Armando Calvo Quiroz, Jose Chavez Corrales, Elias Chalouhi El Khouri, Boris Garro Barrera, Manuel Leon-Portocarrero, Alejandro Miranda Pinto, Risto Perich Campos, Félix Romero Peña, Jan Brzezicki, Dariusz Chudzik, Magdalena Dmoszynska-Graniczka, Krystyna Dworak, Barbara Grabowicz-Wasko, Pawel Hrycaj, Slawomir Jeka, Marek Konieczny, Marek Krogulec, Jaroslaw Marcinkiewicz, Agnieszka Ewa Pawtel, Artur Racewicz, Maria Rell-Bakalarska, Zofia Ruzga, Karina Sitek-Ziolkowska, Maria Stopinska-Polaszewska, Anna Sylwestrzak, Leszek Szczepanski, Piotr Wiland, Agnieszka Zielinska, Grisell Ortiz-Lasanta, Jose Ramirez-Vazquez, Ramon Toro Torres, Alina Agafina, Grigory Arutyunov, Valeria Esip, Elena Grunina, Nadezhda Izmozherova, Natalya Khalaydzhi, Irina Marusenko, Tatyana Mikhaylova, Andrey Sarana, Ivan Shirinsky, Evgeniya Shmidt, Olga Stetsiouk, Peter Belica, Livia Bruskova, Pavol Dobrovodsky, Viola Husarova, Roman Jancovic, Andrea Skublova, Agnesa Szolnokiova, Johannes Breedt, Maria Du Plooy, Dina Janse Van Rensburg, Asgar Kalla, Faruq Khatib, Ingrid Louw, Savithree Nayiager, Jeanne Nel, Jennifer Potts, Helmuth Reuter, Catherine Spargo, Gareth Tarr, Elsa Van Duuren, Ricardo Blanco Alonso, Ivan Castellvi Barranco, Eugenio Chamizo Carmona, Antonio Fernandez Nebro, Maria Luz Garcia Vivar, Beatriz Joven Ibanez, Isabel Mateo Bernardo, Elisabet Montori Palacin, Carmen Moragues Pastor, Alberto Alonso Ruiz, Federico Navarro Sarabia, Jose Javier Perez Venegas, Manuel Enrique Pombo Suarez, Eduardo Ucar Angulo, Carmen Vargas Lebron, Ying-Ming Chiu, Chien-Chih Lai, Ning-Sheng Lai, Joung-Liang Lan, Hsiao-Yi Lin, Ming-Fei Liu, Mei-Ping Liu, Shue-Fen Luo, Ya-Chih Tien, Cheng-Chung Wei, Chia-Tse Weng, Paijit Asavatanabodee, Wanruchada Katchamart, Worawit Louthrenoo, Kanokrat Nantiruj, Boonjing Siripaitoon, Sebnem Ataman, Ayse Erguney Cefle, Savas Gursoy, Gulen Hatemi, Sami Hizmetli, Umut Kalyoncu, Omer Karadag, Senol Kobak, Omer Kuru, Ahmet Onat, Ali Taylan, Yasemin Turan, Hasan Ulusoy, Orhan Zengin, Teresa Doherty, Robert Moots, Wan Fai Ng, Selwyn Richards, Euthalia Roussou, Thomas Sheeran, David Walker, Jacob Aelion, Jeffrey Alloway, Cristina Arriens, Kwabena Ayesu, Herbert Baraf, Linda Belhorn, Anupama Bhat, Barbara Bode, Stephen Bookbinder, Mark Box, Timothy Brennan, James Calmes, Robert Capps, John Carter, Anurekha Chadha, Victor Chen, Melvin Churchill, Andreea Coca, Asif Cochinwala, Christine Codding, Jeffrey Curtis, Kathryn Dao, Craig Davis, John Davis, Nimesh Dayal, Belkis Delgado, Roger Diegel, Ara Dikranian, Erdal Diri, Geoffrey Dolan, Robin Dore, Sharon Dowell, Michelle Eisenberg, Mitchell Feinman, Justus Fiechtner, Beata Filip-Majewski, Joseph Forstot, Pamela Freeman, David Goddard, Marc Goldberg, Misael Gonzalez, John Gorman, Maria Greenwald, Robert Griffin, Ramesh Gupta, Dale Halter, Robert Harrell, Mark Harris, John Harshbarger, Douglas Haselwood, Sabine Hazan-Steinberg, Ammar Hemaidan, Geneva Hill, Diane Horowitz, Mary Howell, John Hull, Richard Jones, John Joseph, Vipul Joshi, Joshua June, Gurjit Kaeley, Kenneth Kalunian, George Karpouzas, Paul Katzenstein, Ratinder Kaur, Jonathan Kay, Kimberly Kendall, William Kim, Alan Kivitz, Steven Klein, Michael Kohen, Chian Kwoh, Robert LaGrone, Jeffrey Lawson, Clarence Legerton, Robert Levin, Roger Lidman, Jefrey Lieberman, Jeffrey Lisse, Mitchell Lowenstein, Michael Luggen, Basit Malik, Jyothi Mallepalli, Joan Merrill, Samy Metyas, Wesley Mizutani, Joseph Moran, Sabeen Najam, Nathaniel Neal, Tony Ning, Ghaith Noaiseh, Kurt Oelke, Ewa Olech, Meera Oza, Dennis Ozment, William Palmer, Dayton Payne, Samuel Pegram, Dianne Petrone, Jeffrey Poiley, Andrew Porges, Henry Prupas, Madura Rangaraj, Ronald Rapoport, Andreas Reimold, David Ridley, Jeffrey Ritter, Georgia Roane, Michael Robinson, Adam Rosen, Constantine Saadeh, Michael Sayers, William Schnitz, Anthony Sebba, William Shergy, Robert Shurmur, David Sikes, Atul Singhal, Yvonne Smallwood-Sherrer, Nowarat Songsiridej, Michael Stack, Melody St John, William Stohl, Tien-I Su, Dominick Sudano, Andrew Sulich, Prashanth Sunkureddi, Paul Sutej, Timothy Swartz, Suman Thakker, Aikaterini Thanou, Robert Trapp, Orrin Troum, David True, Yong-Hsiung Tsai, James Udell, Fehmida Zahabi Unwala, Jacqueline Vo, Philip Waller, Saleem Waraich, Nathan Wei, Charles Weidmann, Craig Wiesenhutter, Anne Winkler, Sanford Wolfe, Darice Yang, Karen Zagar |
| 79 | |
Proteomic Approaches to Defining Remission and the Risk of Relapse in Rheumatoid Arthritis |
Front Immunol. 2021 Nov 18;12:729681.doi: 10.3389/fimmu.2021.729681. eCollection 2021. Liam J O'Neil 1 2, Pingzhao Hu 3 4, Qian Liu 3 4, Md Mohaiminul Islam 3 4, Victor Spicer 2, Juergen Rech 5, Axel Hueber 5, Vidyanand Anaparti 2, Irene Smolik 1, Hani S El-Gabalawy 1 2, Georg Schett 5, John A Wilkins 1 2 |
| 80 | |
Effects of a Weight and Pain Management Program in Patients With Rheumatoid Arthritis With Obesity: A Randomized Controlled Pilot Investigation |
J Clin Rheumatol. 2022 Jan 1;28(1):7-13.doi: 10.1097/RHU.0000000000001793. Tamara J Somers 1, James A Blumenthal 1, Caroline S Dorfman 1, Kim M Huffman 2, Sara N Edmond, Shannon N Miller 1, Anava A Wren 3, David Caldwell 4, Francis J Keefe 1 |
| 81 | |
Evaluating filgotinib for the treatment of rheumatoid arthritis |
Expert Opin Pharmacother. 2021 Dec;22(18):2435-2444.doi: 10.1080/14656566.2021.1967929. Epub 2021 Aug 26. |
| 82 | |
Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits |
Arthritis Care Res (Hoboken). 2021 Dec;73(12):1809-1814. doi: 10.1002/acr.24429. Bryant R England 1, Claire E H Barber 2, Martin Bergman 3, Veena K Ranganath 4, Lisa G Suter 5, Kaleb Michaud 6 |
| 83 | |
The Interleukin-1 Receptor-Associated Kinase 4 Inhibitor PF-06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial |
Arthritis Rheumatol. 2021 Dec;73(12):2206-2218.doi: 10.1002/art.41953. Epub 2021 Nov 1. Aaron Winkler 1, Weiyong Sun 1, Saurav De 2, Aiping Jiao 1, M Nusrat Sharif 1, Peter T Symanowicz 1, Shruti Athale 3, Julia H Shin 1, Ju Wang 1, Bruce A Jacobson 1, Simeon J Ramsey 1, Ken Dower 1, Tatyana Andreyeva 1, Heng Liu 1, Martin Hegen 1, Bruce L Homer 1, Joanne Brodfuehrer 1, Mera Tilley 1, Steven A Gilbert 1, Spencer I Danto 1, Jean J Beebe 1, Betsy J Barnes 2, Virginia Pascual 3, Lih-Ling Lin 1, Iain Kilty 1, Margaret Fleming 1, Vikram R Rao 1 |
| 84 | |
The impact of filgotinib on patient-reported outcomes and health-related quality of life for patients with active rheumatoid arthritis: a post hoc analysis of Phase 3 studies |
Arthritis Res Ther. 2022 Jan 3;24(1):11. doi: 10.1186/s13075-021-02677-7. Clifton O Bingham 3rd 1, David Walker 2, Peter Nash 3, Susan J Lee 4, Lei Ye 4, Hao Hu 4, Javaria Mona Khalid 5, Bernard Combe 6 |
| 85 | |
Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants |
Clin Pharmacol Drug Dev. 2022 Feb;11(2):235-245.doi: 10.1002/cpdd.1015. Epub 2021 Sep 1. Kacey Anderson 1, Cara H Nelson 1, Qi Gong 1, Muhsen Alani 1 2, Thomas Tarnowski 1, Ahmed A Othman 1 |
| 86 | |
Weight Fluctuation and the Risk of Cardiovascular Events in Patients With Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Feb;74(2):229-235. doi: 10.1002/acr.24469.Epub 2022 Jan 5. |
| 87 | |
Post Hoc Analysis of Predictors of Clinical Response to Repository Corticotropin Injection in Persistently Active Rheumatoid Arthritis |
Rheumatol Ther. 2022 Apr;9(2):649-661. doi: 10.1007/s40744-022-00429-w.Epub 2022 Feb 20. Roy Fleischmann 1, Kyle Hayes 2, Sung-Woo Ahn 3, George J Wan 2, Mary Panaccio 2, Daniel Karlsson 2, Daniel E Furst 4 |
| 88 | |
Circulating Adipokines and Associations with Incident Cardiovascular Disease in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Mar 21. doi: 10.1002/acr.24885. Online ahead of print. Lydia E Federico 1, Tate M Johnson 2 3, Bryant R England 2 3, Katherine D Wysham 4 5, Michael D George 1 6, Brian Sauer 7 8, Bartlett C Hamilton 3, Carlos D Hunter 3, Michael J Duryee 3, Geoffrey M Thiele 2 3, Ted R Mikuls 2 3, Joshua F Baker 1 6 9 |
| 89 | |
Investigation Into the Effect of COVID-19 Infection on Length of Hospital Stay and Mortality in Patients With Rheumatoid Arthritis |
Cureus. 2022 Feb 28;14(2):e22685. doi: 10.7759/cureus.22685. eCollection 2022 Feb. Kevin Thompson 1, Ami Shah 2, Adam Grunbaum 3, Olu Oyesanmi 4 |
| 90 | |
Alcohol consumption and the risk of mortality and myocardial infarction in patients with rheumatoid arthritis |
Clin Exp Rheumatol. 2022 Jan 25. doi: 10.55563/clinexprheumatol/8snr4x. Online ahead of print. Isaac D Smith 1, Na Lu 2, Jie Wei 2, Yuqing Zhang 2, Hyon K Choi 2, Marcy B Bolster 2 |
| 91 | |
Frequency of symptomatic adverse events in rheumatoid arthritis: an exploratory online survey |
J Rheumatol. 2022 Mar 1;jrheum.210688. doi: 10.3899/jrheum.210688. Online ahead of print. Glen S Hazlewood 1, Orit Schieir 1, Vivian Bykerk 1, Kamso Mujaab 1, Peter Tugwell 1, George Wells 1, Dawn Richards 1, Laurie Proulx 1, Pauline M Hull 1, Susan J Bartlett 1 |
| 92 | |
The Use of Telehealth for Psychological Counselling of Vulnerable Adult Patients With Rheumatic Diseases or Diabetes: Explorative Study Inspired by Participatory Design |
JMIR Hum Factors. 2022 Mar 21;9(1):e30829. doi: 10.2196/30829. Mette Juel Rothmann 1 2 3 4, Julie Drotner Mouritsen 1 2, Nanna Skov Ladefoged 1 2, Marie Nedergaard Jeppesen 2, Anna Sofie Lillevang 1 2, Helle Laustrup 1 4, Torkell Ellingsen 1 4 |
| 93 | |
Development of a Digital Health Intervention for Rheumatoid Arthritis Symptom Management in a Biotechnology Industry Context: Protocol for the Application of a Human-Centered Design Framework |
MIR Res Protoc. 2022 Mar 22;11(3):e16430. doi: 10.2196/16430. Lisa Nugent # 1, Robin Anthony Kouyate # 1, Shawna Jackson # 1, Meredith Y Smith # 1 |
| 94 | |
Oral surveillance and JAK inhibitor safety: the theory of relativity |
Nat Rev Rheumatol. 2022 Mar 22;1-4. doi: 10.1038/s41584-022-00767-7.Online ahead of print. Kevin L Winthrop 1, Stanley B Cohen 2 |
| 95 | |
Elevations in Adipocytokines and Mortality in Rheumatoid Arthritis |
Rheumatology (Oxford). 2022 Mar 23;keac191. doi: 10.1093/rheumatology/keac191.Online ahead of print. Joshua F Baker 1 2 3, Bryant R England 4, Michael D George 2 3, Katherine Wysham 5 6, Tate Johnson 4, Gary Kunkel 7, Brian Sauer 7, Bartlett C Hamilton 4, Carlos D Hunter 4, Michael J Duryee 4, Paul Monach 8, Gail Kerr 9, Andreas Reimold 10, Rui Xiao 3, Geoff M Thiele 4, Ted R MIkuls 4 |
| 96 | |
Usability Study of PF-06410293, an Adalimumab Biosimilar, by Prefilled Pen: Open-Label, Single-Arm, Sub-Study of a Phase 3 Trial in Patients with Rheumatoid Arthritis |
Rheumatol Ther. 2022 Mar 18. doi: 10.1007/s40744-022-00439-8. Online ahead of print. Roy M Fleischmann 1, Amy E Bock 2, Wuyan Zhang 3, Charles M Godfrey 4, Ivana Vranic 5, Carol Cronenberger 6, Eva Dokoupilová 7 8 |
| 97 | |
Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis-Associated Bronchiectasis: Role of RA-related Autoantibodies |
J Rheumatol. 2022 Mar 15;jrheum.211242. doi: 10.3899/jrheum.211242. Online ahead of print. Gregory McDermott 1, Ritu Gill 1, Staci Gagne 1, Suzanne Byrne 1, Weixing Huang 1, Xiaosong Wang 1, Lauren C Prisco 1, Alessandra Zaccardelli 1, Lily W Martin 1, Lucy Masto 1, Vanessa L Kronzer 1, Nancy Shadick 1, Paul F Dellaripa 1, Tracy J Doyle 1, Jeffrey A Sparks 1 |
| 98 | |
Presence of Autoantibodies in Males and Females with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis |
J Rheumatol. 2022 Mar 15;jrheum.211020. doi: 10.3899/jrheum.211020. Online ahead of print. Brook Hadwen 1, Richard Yu 1, Ewa Cairns 1, Lillian Barra 1 |
| 99 | |
Associations of the MUC5B Promoter Variant with Timing of Interstitial Lung Disease and Rheumatoid Arthritis Onset |
Rheumatology (Oxford). 2022 Mar 15;keac152. doi: 10.1093/rheumatology/keac152.Online ahead of print. Gregory McDermott 1 2, Ritu Gill 3 2, Staci Gagne 4 2, Suzanne Byrne 4 2, Weixing Huang 1, Jing Cui 1 2, Lauren Prisco 1, Alessandra Zaccardelli 1, Lily Martin 1, Vanessa L Kronzer 5, Matthew Moll 6 7 2, Michael H Cho 6 7 2, Nancy Shadick 1 2, Paul F Dellaripa 1 2, Tracy Doyle 6 2, Jeffrey A Sparks 1 2 |
| 100 | |
Achieving pain control in early rheumatoid arthritis with baricitinib monotherapy or in combination with methotrexate versus methotrexate monotherapy |
RMD Open. 2022 Mar;8(1):e001994. doi: 10.1136/rmdopen-2021-001994. Peter C Taylor 1, Rieke Alten 2, Jose María Álvaro Gracia 3, Yuko Kaneko 4, Chad Walls 5, Amanda Quebe 5, Bochao Jia 5, Natalia Bello 5, Jorge Ross Terres 5, Roy Fleischmann 6 |
| 101 | |
Microstructural Bone Changes Are Associated With Broad-Spectrum Autoimmunity and Predict the Onset of Rheumatoid Arthritis |
Arthritis Rheumatol. 2022 Mar;74(3):418-426. doi: 10.1002/art.41229. Epub 2022 Jan 27. David Simon 1, Arnd Kleyer 1, Duy Bui Cong 1, Axel Hueber 1, Holger Bang 2, Andreas Ramming 1, Juergen Rech 1, Georg Schett 1 |
| 102 | |
Defining Minimum Clinically Important Changes for the Patient Activity Scale II |
Arthritis Care Res (Hoboken). 2021 Oct;73(10):1456-1460.doi: 10.1002/acr.24335. Epub 2021 Aug 20. Joshua F Baker 1, Patti Katz 2, Kaleb Michaud 3 |
| 103 | |
Long-term Outcomes of MCP Surface Replacement Arthroplasty in Patients With Rheumatoid Arthritis |
Hand (N Y). 2022 Mar;17(2):271-277. doi: 10.1177/1558944720926631. Epub 2020 Jun 2. Matthew R Claxton 1, Eric R Wagner 2, Marco Rizzo 1 |
| 104 | |
Patient-reported outcomes and realistic clinical endpoints for JAK inhibitors in rheumatoid arthritis |
Expert Rev Clin Immunol. 2022 Mar 2. doi: 10.1080/1744666X.2022.2049242.Online ahead of print. Vibeke Strand 1 |
| 105 | |
Obesity and Response to Advanced Therapies in Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2022 Feb 10. doi: 10.1002/acr.24867. Online ahead of print. Joshua F Baker 1 2 3, George Reed 4, Dilli Ram Poudel 5, Leslie R Harrold 4 6, Joel M Kremer 4 7 |
| 106 | |
Recent issues in JAK inhibitor safety: perspective for the clinician |
Expert Rev Clin Immunol. 2022 Feb 10;1-13. doi: 10.1080/1744666X.2022.2039122.Online ahead of print. Roy Fleischmann 1 2 |
| 107 | |
Patient Goals for Living with Rheumatoid Arthritis: A Qualitative Study |
Clin Nurs Res. 2022 Feb 7;10547738221075784. doi: 10.1177/10547738221075784.Online ahead of print. Melanie J Cozad 1, Lisa C Lindley 2, Kaitlyn Crosby 3, Noor Alshareef 4, Ann Blair Kennedy 5, Gulzar Merchant 6, Pam Evans 7, Ronnie D Horner 1 |
| 108 | |
Long-term safety and efficacy of upadacitinib or adalimumab in patients with rheumatoid arthritis: results through 3 years from the SELECT-COMPARE study |
RMD Open. 2022 Feb;8(1):e002012. doi: 10.1136/rmdopen-2021-002012. Roy Fleischmann 1, Eduardo Mysler 2, Louis Bessette 3, Charles G Peterfy 4, Patrick Durez 5, Yoshiya Tanaka 6, Jerzy Swierkot 7, Nasser Khan 8, Xianwei Bu 8, Yihan Li 8, In-Ho Song 8 |
| 109 | |
Incidence and risk factors for herpes zoster in patients with rheumatoid arthritis receiving upadacitinib: a pooled analysis of six phase III clinical trials |
Ann Rheum Dis. 2022 Feb;81(2):206-213. doi: 10.1136/annrheumdis-2021-220822.Epub 2021 Oct 6. Kevin L Winthrop 1, Peter Nash 2, Kunihiro Yamaoka 3, Eduardo Mysler 4, Nasser Khan 5, Heidi S Camp 5, Yanna Song 5, Jessica L Suboticki 5, Jeffrey R Curtis 6 |
| 110 | |
The erratic C-reactive protein: a novel outcome measure for longitudinal disease activity in rheumatoid arthritis |
Clin Exp Rheumatol. 2021 Sep 21. Online ahead of print. |
| 111 | |
Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis |
Front Immunol. 2021 Sep 14;12:715997. doi: 10.3389/fimmu.2021.715997. eCollection 2021. Liam J O'Neil 1, Christopher B Oliveira 1, Donavon Sandoval-Heglund 1, Ana Barrera-Vargas 2, Javier Merayo-Chalico 2, Eduardo Aguirre-Aguilar 2, Mariana J Kaplan 1, Carmelo Carmona-Rivera 1 |
| 112 | |
Filgotinib as rheumatoid arthritis therapy |
Drugs Today (Barc). 2021 Sep;57(9):543-550. doi: 10.1358/dot.2021.57.9.3317241. A Becciolini 1, E Di Donato 2, D Santilli 2, G Lucchini 2, F Mozzani 2, M Riva 2, A Ariani 2 |
| 113 | |
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis |
Adv Ther. 2021 Dec;38(12):5649-5661. doi: 10.1007/s12325-021-01930-4. Epub 2021 Oct 12. Martin Bergman 1, Namita Tundia 2, Min Yang 3, Eli Orvis 3, Jerry Clewell 2, Arielle Bensimon 4 |
| 114 | |
Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model |
Int J Mol Sci. 2021 Jul 5;22(13):7224. doi: 10.3390/ijms22137224. Alexander Otahal 1, Karina Kramer 1, Olga Kuten-Pella 2, Lukas B Moser 1, Markus Neubauer 1, Zsombor Lacza 2 3, Stefan Nehrer 1, Andrea De Luna 1 |
| 115 | |
Systematic review of safety and efficacy of belimumab in treating immune-mediated disorders |
Allergy. 2021 Sep;76(9):2673-2683. doi: 10.1111/all.14704. Epub 2020 Dec 26. Celine Kaegi 1, Urs C Steiner 1, Benjamin Wuest 1, Catherine Crowley 1, Onur Boyman 1 2 |
| 116 | |
Effectiveness of initial methotrexate-based treatment approaches in early rheumatoid arthritis: an elicitation of rheumatologists' beliefs |
Rheumatology (Oxford). 2021 Aug 2;60(8):3570-3578.doi: 10.1093/rheumatology/keaa803. Gyanendra Pokharel 1, Rob Deardon 2, Sindhu R Johnson 3 4, George Tomlinson 4, Pauline M Hull 5, Glen S Hazlewood 5 6 |
| 117 | |
Efficacy, Safety, and Immunogenicity of Biosimilar Etanercept (Enerceptan) Versus Its Original Form in Combination With Methotrexate in Patients With Rheumatoid Arthritis: A Randomized, Multicenter, Evaluator-Blinded, Noninferiority Study |
J Clin Rheumatol. 2021 Sep 1;27(6S):S173-S179.doi: 10.1097/RHU.0000000000001616. Ingrid Strusberg 1, Eduardo Mysler 2, Gustavo Citera 3, Daniel Siri 4, Maria de Los Ángeles Correa 5, Maria Alicia Lazaro 6, Rodolfo Pardo Hidalgo 7, Alberto Spindler 8, Patricio Tate 9, Horacio Venarotti 10, Jorge Velasco Zamora 11, Ezequiel Klimovsky 12, Andrea Federico 12, Eduardo Scheines 13, Eliseo Gonzalez 14, Lucas Cordeiro 15, Nestor Lago 15 |
| 118 | |
Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease |
Rheumatology (Oxford). 2021 Aug 2;60(8):3778-3788. doi: 10.1093/rheumatology/keaa860. Nadia M T Roodenrijs 1, Marlies C van der Goes 1 2, Paco M J Welsing 1, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 119 | |
Patients' and rheumatologists' perspectives on the efficacy and safety of low-dose glucocorticoids in rheumatoid arthritis-an international survey within the GLORIA study |
Rheumatology (Oxford). 2021 Jul 1;60(7):3334-3342. doi: 10.1093/rheumatology/keaa785. T Santiago 1 2, M Voshaar 3, M de Wit 4, P D Carvalho 5 6 7, F Buttgereit 8, M Cutolo 9, S Paolino 9, G R Castelar Pinheiro 10, M Boers 11, J A P Da Silva 1 2 |
| 120 | |
Comparison of Clinical Manifestations in Rheumatoid Arthritis vs. Spondyloarthritis: A Systematic Literature Review |
Rheumatol Ther. 2021 Dec 28. doi: 10.1007/s40744-021-00407-8.Online ahead of print. Philip J Mease 1 2, Mohit Kumar Bhutani 3, Steven Hass 4, Esther Yi 5, Peter Hur 5, Nina Kim 6 7 |
| 123 | |
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study |
Clin Exp Rheumatol. Jul-Aug 2021;39(4):868-873. Epub 2020 Dec 18. Giacomo Maria Guidelli 1, Ombretta Viapiana 2, Nicoletta Luciano 1, Maria De Santis 1, Nicola Boffini 3, Luca Quartuccio 4, Domenico Birra 5, Edoardo Conticini 6, Maria Sole Chimenti 7, Chiara Bazzani 8, Eleonora Bruschi 9, Marta Riva 10, Lorenzo Maria Canziani 11, Gerolamo Bianchi 12, Maria Rosa Pozzi 10, Massimiliano Limonta 9, Roberto Gorla 8, Roberto Perricone 7, Bruno Frediani 6, Paolo Moscato 5, Salvatore De Vita 4, Lorenzo Dagna 3, Maurizio Rossini 2, Carlo Selmi 13 |
| 125 | |
Role of joint damage, malalignment and inflammation in articular tenderness in rheumatoid arthritis, psoriatic arthritis and osteoarthritis |
Ann Rheum Dis. 2021 Jul;80(7):884-890. doi: 10.1136/annrheumdis-2020-218744.Epub 2021 Jan 12. Irina Gessl 1, Mihaela Popescu 2, Victoria Schimpl 3, Gabriela Supp 1, Thomas Deimel 1, Martina Durechova 1, Miriam Hucke 4, Michaela Loiskandl 1, Paul Studenic 1, Michael Zauner 1, Josef S Smolen 1, Daniel Aletaha 1, Peter Mandl 5 |
| 126 | |
Widespread non-joint pain in early rheumatoid arthritis |
Scand J Rheumatol. 2021 Jul;50(4):271-279. doi: 10.1080/03009742.2020.1846778.Epub 2021 Feb 25. Mec Schelin 1 2, H Westerlind 3 4, J Lindqvist 5 6, E Englid 5, L Israelsson 5, E Skillgate 3, L Klareskog 5 6, L Alfredsson 3, J Lampa 5 6 |
| 127 | |
Higher mortality rates associated with rheumatoid arthritis in Saskatchewan, Canada, 2001-2019 |
Can J Public Health. 2021 Aug;112(4):722-732. doi: 10.17269/s41997-021-00476-w.Epub 2021 Feb 17. Regina M Taylor-Gjevre 1, Bindu V Nair 2, Shan Jin 3, Jacqueline Quail 3 4 |
| 128 | |
Outcomes of a Mobile App to Monitor Patient-Reported Outcomes in Rheumatoid Arthritis: A Randomized Controlled Trial |
Arthritis Rheumatol. 2021 Aug;73(8):1421-1429.doi: 10.1002/art.41686. Epub 2021 Jun 18. Yvonne C Lee 1, Fengxin Lu 2, Joshua Colls 2, Dee Luo 2, Penny Wang 2, Dorothy D Dunlop 1, Lutfiyya N Muhammad 1, Jing Song 1, Kaleb Michaud 3, Daniel H Solomon 2 |
| 129 | |
Healthcare utilization and economic burden of difficult-to-treat rheumatoid arthritis: a cost-of-illness study |
Rheumatology (Oxford). 2021 Oct 2;60(10):4681-4690. doi: 10.1093/rheumatology/keab078. Nadia M T Roodenrijs 1, Paco M J Welsing 1, Marlies C van der Goes 1 2, Janneke Tekstra 1, Floris P J G Lafeber 1, Johannes W G Jacobs 1, Jacob M van Laar 1 |
| 130 | |
Pim Kinases as Therapeutic Targets in Early Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Oct;73(10):1820-1830. doi: 10.1002/art.41744. Epub 2021 Aug 24. Nicola J Maney 1, Henrique Lemos 1, Ben Barron-Millar 1, Christopher Carey 1, Ian Herron 1, Amy E Anderson 1, Andrew L Mellor 1, John D Isaacs 2, Arthur G Pratt 2 |
| 131 | |
Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation |
Arthritis Rheumatol. 2021 Jun;73(6):970-979. doi: 10.1002/art.41613. Epub 2021 May 9. Brittany Weber 1, Zeling He 1, Nicole Yang 1, Martin P Playford 2, Dana Weisenfeld 1, Christine Iannaccone 1, Jonathan Coblyn 1, Michael Weinblatt 1, Nancy Shadick 1, Marcelo Di Carli 1, Nehal N Mehta 2, Jorge Plutzky 1, Katherine P Liao 3 |
| 132 | |
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2021 Jul;73(7):924-939. doi: 10.1002/acr.24596. Epub 2021 Jun 8. Liana Fraenkel 1, Joan M Bathon 2, Bryant R England 3, E William St Clair 4, Thurayya Arayssi 5, Kristine Carandang 6, Kevin D Deane 7, Mark Genovese 8, Kent Kwas Huston 9, Gail Kerr 10, Joel Kremer 11, Mary C Nakamura 12, Linda A Russell 13, Jasvinder A Singh 14, Benjamin J Smith 15, Jeffrey A Sparks 16, Shilpa Venkatachalam 17, Michael E Weinblatt 16, Mounir Al-Gibbawi 18, Joshua F Baker 19, Kamil E Barbour 20, Jennifer L Barton 21, Laura Cappelli 22, Fatimah Chamseddine 18, Michael George 23, Sindhu R Johnson 24, Lara Kahale 18, Basil S Karam 18, Assem M Khamis 18, Iris Navarro-Millán 25, Reza Mirza 26, Pascale Schwab 21, Namrata Singh 27, Marat Turgunbaev 28, Amy S Turner 28, Sally Yaacoub 18, Elie A Akl 18 |
| 133 | |
"Associations of Rheumatoid Arthritis and Depressive Symptoms over Time: Are there Differences by Education, Race/Ethnicity, and Gender?" |
Arthritis Care Res (Hoboken). 2021 Jun 13. doi: 10.1002/acr.24730. Online ahead of print. Julia T McQuillan 1, Jennifer A Andersen 2, Terceira A Berdahl 3, Jeff Willett 4 |
| 134 | |
The Therapeutic Landscape of Rheumatoid Arthritis: Current State and Future Directions |
Front Pharmacol. 2021 May 28;12:680043. doi: 10.3389/fphar.2021.680043.eCollection 2021. Shahin Shams 1, Joseph M Martinez 2, John R D Dawson 3, Juan Flores 4, Marina Gabriel 1, Gustavo Garcia 1, Amanda Guevara 2, Kaitlin Murray 5, Noah Pacifici 1, Maxemiliano V Vargas 6, Taylor Voelker 3, Johannes W Hell 2, Judith F Ashouri 7 |
| 135 | |
The relationship between rheumatoid arthritis and diabetes mellitus: a systematic review and meta-analysis |
Cardiovasc Endocrinol Metab. 2021 Feb 19;10(2):125-131.doi: 10.1097/XCE.0000000000000244. eCollection 2021 Jun. Zixing Tian 1, John Mclaughlin 1, Arpana Verma 2, Hector Chinoy 3 4 5, Adrian H Heald 1 1 |
| 136 | |
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Jul;73(7):1108-1123. doi: 10.1002/art.41752. Epub 2021 Jun 8 Liana Fraenkel 1, Joan M Bathon 2, Bryant R England 3, E William St Clair 4, Thurayya Arayssi 5, Kristine Carandang 6, Kevin D Deane 7, Mark Genovese 8, Kent Kwas Huston 9, Gail Kerr 10, Joel Kremer 11, Mary C Nakamura 12, Linda A Russell 13, Jasvinder A Singh 14, Benjamin J Smith 15, Jeffrey A Sparks 16, Shilpa Venkatachalam 17, Michael E Weinblatt 16, Mounir Al-Gibbawi 18, Joshua F Baker 19, Kamil E Barbour 20, Jennifer L Barton 21, Laura Cappelli 22, Fatimah Chamseddine 18, Michael George 23, Sindhu R Johnson 24, Lara Kahale 18, Basil S Karam 18, Assem M Khamis 18, Iris Navarro-Millán 25, Reza Mirza 26, Pascale Schwab 21, Namrata Singh 27, Marat Turgunbaev 28, Amy S Turner 28, Sally Yaacoub 18, Elie A Akl 18 |
| 137 | |
Multimorbidity Accrual After Incident Rheumatoid Arthritis: A Wolf at the Door |
J Rheumatol. 2021 Jun 1;jrheum.210224. doi: 10.3899/jrheum.210224.Online ahead of print. |
| 138 | |
Targeted literature review of current treatments and unmet need in moderate rheumatoid arthritis in the United Kingdom |
Rheumatology (Oxford). 2021 Jun 3;keab464. doi: 10.1093/rheumatology/keab464.Online ahead of print. Peter C Taylor 1, Matthew Woods 2, Catherine Rycroft 2, Priya Patel 3, Sophee Blanthorn-Hazell 3, Toby Kent 3, Marwan Bukhari 4 |
| 139 | |
What Is the Persistence to Methotrexate in Rheumatoid Arthritis, and Does Machine Learning Outperform Hypothesis-Based Approaches to Its Prediction? |
ACR Open Rheumatol. 2021 Jul;3(7):457-463. doi: 10.1002/acr2.11266. Epub 2021 Jun 4. Helga Westerlind 1, Mateusz Maciejewski 2, Thomas Frisell 1, Scott A Jelinsky 2, Daniel Ziemek 2, Johan Askling 1 |
| 142 | |
Unravelling the Cost of Biological Strategies in Rheumatoid Arthritis: A Kaleidoscope of Methodologies, Interpretations, and Interests |
J Rheumatol. 2021 May 15;jrheum.201510. doi: 10.3899/jrheum.201510.Online ahead of print. Johannes W G Jacobs 1, Maxime M A Verhoeven 1, Paco M J Welsing 1 |
| 143 | |
Systematic review and meta-analysis of the reproducibility of patient self-reported joint counts in rheumatoid arthritis |
J Rheumatol. 2021 May 15;jrheum.201439. doi: 10.3899/jrheum.201439. Online ahead of print. Sanketh Rampes 1, Vishit Patel 1, Ailsa Bosworth 1, Clare Jacklin 1, Deepak Nagra 1, Mark Yates 1, Sam Norton 1, James Galloway 1 |
| 144 | |
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis |
Front Immunol. 2021 Apr 29;12:673916. doi: 10.3389/fimmu.2021.673916.eCollection 2021. Sally A Clayton 1 2, Lucy MacDonald 3 4, Mariola Kurowska-Stolarska 3 4, Andrew R Clark 1 2 |
| 145 | |
Investigating changes in disease activity as a mediator of cardiovascular risk reduction with methotrexate use in rheumatoid arthritis |
Ann Rheum Dis. 2021 May 28;annrheumdis-2021-220125.doi: 10.1136/annrheumdis-2021-220125. Online ahead of print. Tate M Johnson 1 2, Harlan R Sayles 1 3, Joshua F Baker 4 5, Michael D George 4 5, Punyasha Roul 1, Cheng Zheng 3, Brian Sauer 6 7, Katherine P Liao 8, Daniel R Anderson 9, Ted R Mikuls 1 2, Bryant R England 10 2 |
| 146 | |
Predicting Response to Tocilizumab Monotherapy in Rheumatoid Arthritis: A Real-World Data Analysis Using Machine Learning |
J Rheumatol. 2021 May 1;jrheum.201626. doi: 10.3899/jrheum.201626. Online ahead of print. Fredrik D Johansson 1, Jamie E Collins 1, Vincent Yau 1, Hongshu Guan 1, Seoyoung C Kim 1, Elena Losina 1, David Sontag 1, Jacklyn Stratton 1, Huong Trinh 1, Jeffrey Greenberg 1, Daniel H Solomon 1 |
| 147 | |
The utility of therapeutic plasma exchange in Hyperviscosity syndrome associated with juvenile rheumatoid arthritis: A case report |
J Clin Apher. 2021 May 4. doi: 10.1002/jca.21903. Online ahead of print. Allen P Green 1, Adam C Gonzalez 2, Jack B Alperin 3, James D Burner 1, Sean G Yates 1 |
| 148 | |
Clinical use of Jak 1 inhibitors for rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii31-ii38.doi: 10.1093/rheumatology/keab265. |
| 149 | |
Phase III trials of JAK1 selective inhibitors in rheumatoid arthritis |
Rheumatology (Oxford). 2021 May 5;60(Supplement_2):ii17-ii23.doi: 10.1093/rheumatology/keaa823. |
| 150 | |
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohort |
Int Immunopharmacol. 2021 Apr 29;97:107719. doi: 10.1016/j.intimp.2021.107719.Online ahead of print. Bryant R England 1, Megan Campany 2, Harlan Sayles 2, Punyasha Roul 2, Yangyuna Yang 2, Apar Kishor Ganti 3, Jeremy Sokolove 4, William H Robinson 5, Andreas M Reimold 6, Gail S Kerr 7, Grant W Cannon 8, Brian C Sauer 8, Joshua F Baker 9, Geoffrey M Thiele 10, Ted R Mikuls 10 |
| 151 | |
Identification and Evaluation of Serum Protein Biomarkers Which Differentiate Psoriatic from Rheumatoid Arthritis |
Arthritis Rheumatol. 2021 Jun 11. doi: 10.1002/art.41899. Online ahead of print. Angela Mc Ardle 1, Anna Kwasnik 1, Agnes Szenpetery 1, Belinda Hernandez 2 3, Andrew Parnell 3, Wilco de Jager 4 5, Sytze de Roock 5, Oliver FitzGerald 1, Stephen R Pennington 1 |
| 152 | |
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study |
Medicine (Baltimore). 2021 Apr 30;100(17):e25481. doi: 10.1097/MD.0000000000025481. Alberto Floris 1, Daniela Perra 1, Ignazio Cangemi 1, Mattia Congia 1, Elisabetta Chessa 1, Maria Maddalena Angioni 1, Arduino Aleksander Mangoni 2, Gian Luca Erre 3, Alessandro Mathieu 1, Matteo Piga 1, Alberto Cauli 3 |
| 153 | |
Clinical and biomechanical factors associated with falls and rheumatoid arthritis: baseline cohort with longitudinal nested case-control study |
Rheumatology (Oxford). 2021 Apr 26;keab388. doi: 10.1093/rheumatology/keab388.Online ahead of print. Toby O Smith 1 2, Celia Clarke 1, Jack R Dainty 1, Laura Watts 1, Max Yates 1 3, Valerie M Pomeroy 1 4, Emma Stanmore 5, Terence W O'Neill Tw 6, Alexander J Macgregor 1 3 |
| 154 | |
Perioperative Management of Antirheumatic Medications in Patients with RA and SLE Undergoing Elective Foot and Ankle Surgery: A Critical Analysis Review |
JBJS Rev. 2021 Jun 8;9(6). doi: 10.2106/JBJS.RVW.20.00201. Noah E Saunders 1, James R Holmes 2, David M Walton 2, Paul G Talusan 3 |
| 155 | |
Efficacy and safety of tofacitinib modified-release 11 mg once daily plus methotrexate in adult patients with rheumatoid arthritis: 24-week open-label phase results from a phase 3b/4 methotrexate withdrawal non-inferiority study (ORAL Shift) |
RMD Open. 2021 Jun;7(2):e001673. doi: 10.1136/rmdopen-2021-001673. Stanley B Cohen 1, Janet Pope 2, Boulos Haraoui 3, Eduardo Mysler 4, Annette Diehl 5, Tatjana Lukic 6, Shixue Liu 7, Lori Stockert 5, Rebecca Germino 6, Sujatha Menon 8, Harry Shi 6, Edward C Keystone 9 |
| 156 | |
Long-term safety and efficacy of sarilumab over 5 years in patients with rheumatoid arthritis refractory to TNF inhibitors |
Rheumatology (Oxford). 2021 Apr 19;keab355. doi: 10.1093/rheumatology/keab355.Online ahead of print. Roy Fleischmann 1, Mark C Genovese 2, Karina Maslova 3, Henry Leher 4, Amy Praestgaard 5, Gerd R Burmester 6 |
| 157 | |
Effect of nurse-led care on outcomes in patients with ACPA/RF-positive rheumatoid arthritis with active disease undergoing treat-to-target: a multicentre randomised controlled trial |
RMD Open. 2021 Apr;7(1):e001627. doi: 10.1136/rmdopen-2021-001627. Juliana Rachel Hoeper 1 2, Jan Zeidler 1, Sara Eileen Meyer 2, Georg Gauler 3, Patricia Steffens-Korbanka 3, Martin Welcker 4, Jörg Wendler 5, Florian Schuch 5, Ulrich von Hinüber 6, Andreas Schwarting 7 8, Torsten Witte 2, Dirk Meyer-Olson 2 9, Kirsten Hoeper 10 |
| 158 | |
Demyelinating Events Following Initiation of Anti-TNFa Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis |
Neurol Neuroimmunol Neuroinflamm. 2021 Apr 16;8(3):e992.doi: 10.1212/NXI.0000000000000992. Print 2021 May. Thomas R P Taylor 1, James Galloway 1, Rebecca Davies 1, Kimme Hyrich 1, Ruth Dobson 2 |
| 159 | |
Epstein-Barr virus -related lymphoma in rheumatoid arthritis: Implications for long-term usage of immunosuppressive drugs and review of the literature |
Intern Med J. 2021 May 24. doi: 10.1111/imj.15390. Online ahead of print. Jianna He 1, Luke Williamson 1, Ken Cai 1, Peter Wong 1 2, Allan Sturgess 3, John Taper 4, Nicholas Manolios 1 5 |
| 160 | |
Efficacy of Long-Term Treatment with Once-Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-Week, Phase III, Randomized, Controlled Studies and One Long-Term Extension Study |
Rheumatol Ther. 2021 May 24. doi: 10.1007/s40744-021-00317-9. Online ahead of print. Alvin F Wells 1, Bochao Jia 2, Li Xie 2, Guillermo J Valenzuela 3, Edward C Keystone 4, Zhanguo Li 5, Amanda K Quebe 6, Kirstin Griffing 2, Susan Otawa 2, Boulos Haraoui 7 |
| 161 | |
Few Adverse Cardiovascular Events among Patients with Rheumatoid Arthritis Receiving Hydroxychloroquine: Are We Reassured? |
Arthritis Rheumatol. 2021 May 13. doi: 10.1002/art.41801. Online ahead of print. |
| 162 | |
Disruptions in Rheumatology Care and the Rise of Telehealth in Response to the COVID19 Pandemic in a Community Practice-Based Network |
Arthritis Care Res (Hoboken). 2021 May 10. doi: 10.1002/acr.24626. Online ahead of print. Michael George 1, Maria I Danila 2, Daniel Watrous 3, Shanmugapriya Reddy 4, Jeffrey Alper 5, Fenglong Xie 2, W Benjamin Nowell 6, Joel Kallich 7, Cassie Clinton 2, Kenneth G Saag 2, Jeffrey R Curtis 2 |
| 163 | |
Meaningful change thresholds for Patient-Reported Outcomes Measurement Information System (PROMIS) fatigue and pain interference scores in patients with rheumatoid arthritis |
J Rheumatol. 2021 Mar 15;jrheum.200990. doi: 10.3899/jrheum.200990. Online ahead of print. Jennifer L Beaumont 1, Elizabeth S Davis 1, James F Fries 1, Jeffrey R Curtis 1, David Cella 1, Huifeng Yun 1 |
| 164 | |
Role of Janus Kinase inhibitors in rheumatoid arthritis treatment |
Curr Opin Rheumatol. 2021 May 1;33(3):300-306. doi: 10.1097/BOR.0000000000000792. |
| 165 | |
Probabilistic Linkage of Randomized Controlled Trial Data to Administrative Claims: A Case Study of Patients from Baricitinib Clinical Trials |
Rheumatol Ther. 2021 Apr 2. doi: 10.1007/s40744-021-00302-2. Online ahead of print. Catherine B McGuiness 1, Natalie N Boytsov 2, Xiang Zhang 2, Xin Wang 3, Carol L Kannowski 2, Rolin L Wade 3 |
| 166 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 167 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 168 | |
Review of Current Real-World Experience with Teriparatide as Treatment of Osteoporosis in Different Patient Groups |
J Clin Med. 2021 Apr 1;10(7):1403. doi: 10.3390/jcm10071403. |
| 169 | |
Durability of Response to Tocilizumab Therapy in Rheumatoid Arthritis: Data from the US-Based Corrona Rheumatoid Arthritis Registry |
Rheumatol Ther. 2021 Mar;8(1):467-481. doi: 10.1007/s40744-021-00285-0. Epub 2021 Feb 25. Dimitrios A Pappas 1, Taylor Blachley 2, Jennie H Best 3, Steve Zlotnick 3, William G Reiss 3, Kelechi Emeanuru 2, Joel M Kremer 2 4 |
| 170 | |
The experience of living with a chronic disease in pediatrics from the mothers' narratives: The Clinical Interview on Parental Sense of Grip on the Disease |
Health Psychol Open. 2020 Dec 8;7(2):2055102920971496. doi: 10.1177/2055102920971496.eCollection Jul-Dec 2020. Livia Savarese 1, Maria Francesca Freda 1, Raffaele De Luca Picione 2, Pasqaule Dolce 3, Raffaella De Falco 4, Maria Alessio 5, Mauro Cancian 6, Adriana Franzese 5, Maria Domenica Guarino 7, Roberto Perricone 7, Angelica Petraroli 8, Riccardo Senter 1, Claudia Traverso 5, Andrea Zanichelli 9, Eugenio Zito 10, Maria Bova 5 |
| 171 | |
Discrepancy Between Multi-Biomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid Arthritis |
Arthritis Care Res (Hoboken). 2021 Feb 28. doi: 10.1002/acr.24583. Online ahead of print. Roy Fleischmann 1, Jingyu Liu 2, Julie Zhu 2, Oscar G Segurado 3, Daniel E Furst 4 |
| 172 | |
The association between increased body mass index and response to conventional synthetic DMARD treatment in rheumatoid arthritis: Results from the METEOR database |
Rheumatology (Oxford). 2021 Apr 30;keab389. doi: 10.1093/rheumatology/keab389.Online ahead of print. Mrinalini Dey 1 2, Sizheng S Zhao 1 2, Robert J Moots 2 3, Sytske Anne Bergstra 4, Robert B Landewe 5 6, Nicola J Goodson 2 |
| 173 | |
Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial |
ACR Open Rheumatol. 2021 May 1. doi: 10.1002/acr2.11256. Online ahead of print. Jon T Giles 1, Pamela M Rist 2, Katherine P Liao 2, Ahmed Tawakol 3, Zahi A Fayad 4, Venkatesh Mani 4, Nina P Paynter 2, Paul M Ridker 2, Robert J Glynn 2, Fengxin Lu 5, Rachel Broderick 1, Meredith Murray 5, Kathleen M M Vanni 5, Daniel H Solomon 2, Joan M Bathon 1 |
| 174 | |
Clinical management of patients with rheumatoid arthritis during the COVID-19 pandemic |
Expert Rev Clin Immunol. 2021 Apr 14;1-11. doi: 10.1080/1744666X.2021.1908887.Online ahead of print. Ennio Giulio Favalli 1, Gabriella Maioli 1, Martina Biggioggero 1, Roberto Caporali 1 2 |
| 175 | |
Treatment Satisfaction, Patient Preferences, and the Impact of Suboptimal Disease Control in a Large International Rheumatoid Arthritis Cohort: SENSE Study |
Patient Prefer Adherence. 2021 Feb 17;15:359-373. doi: 10.2147/PPA.S289692. eCollection 2021. Peter C Taylor 1, Codrina Ancuta 2, Orsolya Nagy 3, María C de la Vega 4, Andrey Gordeev 5, Radka Janková 6, Umut Kalyoncu 7, Ivan Lagunes-Galindo 3, Jadranka Morovic-Vergles 8, Mariana Peixoto G U E Silva de Souza 9, Bernadette Rojkovich 10, Prodromos Sidiropoulos 11, Atsushi Kawakami 12 |
| 176 | |
Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof |
J Med Chem. 2021 Feb 25;64(4):2228-2241. doi: 10.1021/acs.jmedchem.0c01952.Epub 2021 Feb 11. Ryan R Davis 1, Baoli Li 1, Sang Y Yun 2, Alice Chan 1, Pradeep Nareddy 1, Steven Gunawan 1, Muhammad Ayaz 2, Harshani R Lawrence 2, Gary W Reuther 3, Nicholas J Lawrence 1, Ernst Schönbrunn 1 |
| 177 | |
Managing Cardiovascular Risk in Patients with Rheumatic Disease |
Med Clin North Am. 2021 Mar;105(2):247-262. doi: 10.1016/j.mcna.2020.09.010.Epub 2021 Jan 14. |
| 178 | |
Clinical pharmacology of filgotinib in the treatment of rheumatoid arthritis: current insights |
Expert Rev Clin Pharmacol. 2021 Apr 13;1-10. doi: 10.1080/17512433.2021.1913050.Online ahead of print. Maria Gabriella Raimondo 1, Martina Biggioggero 2, Lavinia Agra Coletto 3, Andreas Ramming 1, Roberto Caporali 2 3, Ennio Giulio Favalli 2 |
| 179 | |
Current treatment strategies in rheumatoid arthritis after methotrexate are not enough to maintain sustained remission: There is no holy grail! |
Arthritis Rheumatol. 2021 Mar 28. doi: 10.1002/art.41746. Online ahead of print. |
| 180 | |
Younger people with rheumatoid arthritis are at increased risk of fracture even before age 50 years: a population-based cohort study |
Osteoporos Int. 2021 Feb 11. doi: 10.1007/s00198-021-05862-1. Online ahead of print. |
| 181 | |
Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry |
Ann Rheum Dis. 2020 Jul;79(7):859-866. doi: 10.1136/annrheumdis-2020-217871.Epub 2020 May 29. Milena Gianfrancesco # 1, Kimme L Hyrich # 2 3, Sarah Al-Adely 2 3, Loreto Carmona 4, Maria I Danila 5, Laure Gossec 6 7, Zara Izadi 1, Lindsay Jacobsohn 1, Patricia Katz 1, Saskia Lawson-Tovey 3 8, Elsa F Mateus 9, Stephanie Rush 1, Gabriela Schmajuk 1, Julia Simard 10, Anja Strangfeld 11, Laura Trupin 1, Katherine D Wysham 12, Suleman Bhana 13, Wendy Costello 14, Rebecca Grainger 15, Jonathan S Hausmann 16 17, Jean W Liew 12, Emily Sirotich 18 19, Paul Sufka 20, Zachary S Wallace 17 21, Jinoos Yazdany # 1, Pedro M Machado # 22 23 24, Philip C Robinson # 25 26, COVID-19 Global Rheumatology Alliance |
| 182 | |
Postapproval Comparative Safety Study of Tofacitinib and Biological Disease-Modifying Antirheumatic Drugs: 5-Year Results from a United States-Based Rheumatoid Arthritis Registry |
ACR Open Rheumatol. 2021 Mar;3(3):173-184. doi: 10.1002/acr2.11232. Epub 2021 Feb 11. Joel M Kremer 1, Clifton O Bingham 3rd 2, Laura C Cappelli 2, Jeffrey D Greenberg 3, Ann M Madsen 4, Jamie Geier 4, Jose L Rivas 5, Alina M Onofrei 6, Christine J Barr 6, Dimitrios A Pappas 7, Heather J Litman 6, Kimberly J Dandreo 6, Andrea B Shapiro 8, Carol A Connell 9, Arthur Kavanaugh 10 |
| 183 | |
The Online Sharing of Instagram Images for Rheumatoid Arthritis |
Comput Inform Nurs. 2020 Jul 24;39(2):89-96. doi: 10.1097/CIN.0000000000000660. |
| 184 | |
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review |
J Clin Med. 2021 Feb 1;10(3):509. doi: 10.3390/jcm10030509. Peter C Taylor 1, Fabiola Atzeni 2, Alejandro Balsa 3, Laure Gossec 4 5, Ulf Müller-Ladner 6, Janet Pope 7 |
| 185 | |
Peripheral Ulcerative Keratitis in Rheumatoid Arthritis Patients Taking Tocilizumab: Paradoxical Manifestation or Insufficient Efficacy? |
Rheumatology (Oxford). 2021 Feb 2;keab093. doi: 10.1093/rheumatology/keab093.Online ahead of print. Florian Cohen 1, Eric Ernest Gabison 2, Sophie Stéphan 2, Rakiba Belkhir 3, Gaetane Nocturne 3 4, Anne-Laurence Best 1, Oscar Haigh 4, Emmanuel Barreau 1, Marc Labetoulle 1 4, Raphaele Seror 3, Antoine Rousseau 1 4 |
| 186 | |
Upadacitinib in Rheumatoid Arthritis: A Benefit-Risk Assessment Across a Phase III Program |
Drug Saf. 2021 Feb 2. doi: 10.1007/s40264-020-01036-w. Online ahead of print. Philip G Conaghan 1, Eduardo Mysler 2, Yoshiya Tanaka 3, Barbara Da Silva-Tillmann 4, Tim Shaw 5, John Liu 4, Ryan Ferguson 4, Jeffrey V Enejosa 4, Stanley Cohen 6, Peter Nash 7, William Rigby 8, Gerd Burmester 9 |
| 187 | |
Location, location, location: how the tissue microenvironment affects inflammation in RA |
Nat Rev Rheumatol. 2021 Feb 1. doi: 10.1038/s41584-020-00570-2.Online ahead of print. Christopher D Buckley 1 2, Caroline Ospelt 3, Steffen Gay 3, Kim S Midwood 4 |
| 188 | |
Safety and Efficacy of Filgotinib: Up to 4-Year Results From an Open-Label Extension Study of Phase 2 Rheumatoid Arthritis Programs |
J Rheumatol. 2021 Feb 1;jrheum.201183. doi: 10.3899/jrheum.201183. Online ahead of print. |